Virios Therapeutics Inc. (NASDAQ: VIRI)
$0.25
-0.0025 ( -1.00% ) 1.2M
Virios Therapeutics Inc is a development-stage biotechnology company. It is focused advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response, such as fibromyalgia ("FM") and Long-COVID ("LC"). Its product candidates includes IMC-1 and IMC-2, IMC-1, is intended to synergistically suppress herpesvirus activation and replication with a more specific activity against the Epstein-Barr virus (herpesvirus HHV-4, IMC-2 is a combination of valacyclovir and celecoxib.
Market Data
Open
$0.25
Previous close
$0.25
Volume
1.2M
Market cap
$6.78M
Day range
$0.24 - $0.26
52 week range
$0.16 - $2.24
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
10-k | Annual reports | 63 | Mar 01, 2024 |
8-k | 8K-related | 16 | Feb 29, 2024 |
4 | Insider transactions | 1 | Feb 28, 2024 |
4 | Insider transactions | 1 | Feb 28, 2024 |
4 | Insider transactions | 1 | Feb 28, 2024 |
4 | Insider transactions | 1 | Feb 28, 2024 |
4 | Insider transactions | 1 | Feb 28, 2024 |
4 | Insider transactions | 1 | Feb 28, 2024 |
4 | Insider transactions | 1 | Feb 28, 2024 |
4 | Insider transactions | 1 | Feb 28, 2024 |